La cadena de opciones muestra datos clave de las opciones de acciones de Australian Oilseeds Hldgs a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Australian Oilseeds Hldgs..

Australian Oilseeds Hldgs (NASDAQ:COOT) Bolsa, Cadena de Opciones

Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently. Company's edible oil sales comprise of two segments: sales of bulk oils to wholesalers who use it as food ingredients or white labeling; sales of packaged oils as the company's own branding to supermarket channels. Sales of protein meals are bulk sales and mainly distributed to local farmers and feedlots as protein supplements.

Australian Oilseeds Holdings Limited - Ordinary Shares

Australian Oilseeds Holdings Ltd

Australian Oilseeds Holdings Limited - Warrant

CooTek (Cayman) Inc

On March 7, 2025, Volcon ePowersports ("Volcon" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>), a provider of electric vehicles today announced that its Board of Directors has authorized a share repurchase program, allowing for the repurchase of up to $2 million of the Company's common stock through March 7, 2026.

News

Buybacks

VLCN

Volcon Announces Board Authorization Of $2M Share Repurchase Program

B of A Securities analyst Joshua Shanker maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Buy and lowers the price target from $333 to $318.

Price Target

Analyst Ratings

B of A Securities Maintains Buy on Progressive, Lowers Price Target to $318

BloomZ Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) ("BloomZ" or the "Company"), a Japanese audio production, VTuber, entertainment, and voice actor management company, announced the appointment of Ryoshin Nakade as the co-Chief Executive Officer and co-Chairman of the Board, effective March 7, 2025. In this role, Mr. Nakade will serve alongside co-Chief Executive Officer Kazusa Aranami to lead the Company into its next phase of growth.

Management

BLMZ

BloomZ Appoints Ryoshin Nakade As Co-Chief Executive Officer And Co-Chairman Of The Board

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
Clears the way to finalize Phase 3 protocol and recruit sites for U.S.
Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match
Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the results of its Type C meeting with the U.S. Food and Drug Administration ("FDA") regarding the protocol for the planned registrational Phase 3 study of eRapa in familial adenomatous polyposis ("FAP").
The Type C meeting followed a productive End of Phase 2 meeting with FDA and the publication of Phase 2 data of eRapa in FAP at six months at Digestive Disease Week in May 2024 and 12 months data at InSight, Barcelona in June 2024. The Type C meeting included a discussion of the statistical plan, the safety database and, most importantly, a composite endpoint for the Phase 3 study. FDA representatives from both Gastroenterology and Oncology Divisions provided valuable input into the proposed program and the Company believes there is a clear path forward for initiation of the registrational Phase 3 study in FAP in the U.S. next quarter.
The planned registrational Phase 3 study of eRapa in FAP will be a double-blind placebo-controlled trial in 168 patients, randomized 2:1 drug / placebo. It is expected the study will be conducted in approximately 30 clinical sites across the US and Europe. The US component of the study will be conducted by LumaBridge, based in San Antonio, Texas and the European component will be conducted by Precision for Medicine LLC. The Phase 3 study is supported by a $17.0 million grant from the Cancer Prevention Research Institute of Texas ("CPRIT") and a Company match of $8.5 million which has already been paid, in full, into escrow.

Biotech

General

BDRX

Biodexa Announces Outcome Of Type C Meeting With FDA Regarding The Phase 3 Program For eRapa In FAP; Clears The Way To Finalize Phase 3 Protocol And Recruit Sites For U.S.

B of A Securities analyst Tal Liani initiates coverage on SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) with a Buy rating and announces Price Target of $27.5.

Initiation

SAIL

B of A Securities Initiates Coverage On SailPoint with Buy Rating, Announces Price Target of $27.5

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COYA#NASDAQ">COYA</a>) with a Buy and maintains $15 price target.

COYA

D. Boral Capital Maintains Buy on Coya Therapeutics, Maintains $15 Price Target

LIXT

LIXTE Biotechnology Announces Pre-Clinical Data Published In BioXriv And International Journal Of Pharmaceutics Confirming LB-100's Conversion To Active Form Endothall, An Effective Cancer Treatment In Combination With Immunotherapy; Potential Biomarker Identified For LB-100 Response

B of A Securities analyst Tim Anderson initiates coverage on Aardvark Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AARD#NASDAQ">AARD</a>) with a Buy rating and announces Price Target of $22.

AARD

B of A Securities Initiates Coverage On Aardvark Therapeutics with Buy Rating, Announces Price Target of $22

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="936" height="556" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1.jpeg" alt="" class="wp-image-7488" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1.jpeg 936w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1-300x178.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1-768x456.jpeg 768w" sizes="(max-width: 936px) 100vw, 936px" /></figure>
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5e970678-71d0-4cb6-9011-2f2ab5f7ceac_1024x608.png" target="_blank" rel="noreferrer noopener"></a>When companies withdraw guidance, you know uncertainty is high.
The word "uncertainty" gets thrown around a lot in discussions about the stock market.
And it's not surprising. There is&nbsp;<a href="https://www.tker.co/p/always-risks-uncertainty-in-stock-market">literally always</a>&nbsp;something to be uncertain about. In fact, uncertainty defines the risk stock market investors take as they bet on a future that isn't guaranteed. Uncertainty gives risk-tolerant investors the opportunity to buy stocks at a discount. Uncertainty is why the returns in the stock market tend to be relatively high.
But far too often, pundits will appear on TV or get quoted in a news article casually saying that "uncertainty is elevated" — when in fact uncertainty may be at normal levels. Because there is always uncertainty, and any implication that there can be periods with no uncertainty is ridiculous.
Of course, there are times when uncertainty explodes above typical levels. And they come with some very glaring signs.
When companies everywhere withdraw guidance &#x1f9d1;&#x1f3fb;&#x200d;&#x1f9af;&#x200D;&#x27a1;&#xFE0F;
Five years ago this week, the World Health Organization&nbsp;<a href="https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020">declared</a>&nbsp;that COVID-19 as a pandemic.
In the weeks prior, there had already been concerns about the seriousness of the outbreak. But it wasn't until mid-March that we began to see huge parts of the economy get shut down in the effort to contain the spread of the virus. And it would be months before we got a sense of what this unprecedented disruption would mean for the economy.
Businesses around the world were not prepared.
Most companies operate assuming a range of probable future outcomes. And for many publicly traded companies, the midpoint of that range is presented to investors in the form of quarterly and annual financial guidance. As the quarter and year proceeds, companies will sometimes raise guidance. Sometimes they'll lower guidance.
Things have to get really bad for companies to withdraw or suspend guidance.
That's exactly&nbsp;<a href="https://finance.yahoo.com/news/corporations-suspend-withdraw-earnings-guidance-analysts-strategists-blind-134417231.html">what a flood of companies did</a>&nbsp;in early 2020 as they had little to no visibility into what business would look like in the near term.
<a href="https://x.com/SamRo/status/1249814452649803777">According to BofA</a>, 71 S&amp;P 500 companies withdrew guidance from March 2 to April 7 that year.
Zooming out a bit, 173 Russell 3000 companies withdrew guidance during the first quarter,&nbsp;<a href="https://www.spglobal.com/content/dam/spglobal/mi/en/documents/general/QR-Brief-Cold-Turkey-Navigating-Guidance-Withdrawal-with-Supply-Chain_Data.pdf">according to S&amp;P Global</a>. The chart below shows how unusual that was.
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0c40d76f-4f39-4cd7-82cd-a980aae76630_1474x1142.png" target="_blank" rel="noreferrer noopener"></a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="935" height="724" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1-1.jpeg" alt="" class="wp-image-7489" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1-1.jpeg 935w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1-1-300x232.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/10121108/image-1-1-768x595.jpeg 768w" sizes="(max-width: 935px) 100vw, 935px" /></figure>
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0c40d76f-4f39-4cd7-82cd-a980aae76630_1474x1142.png" target="_blank" rel="noreferrer noopener"></a>
In Q1 2020, 173 Russell 3000 companies withdrew guidance. (Source:&nbsp;<a href="https://www.spglobal.com/content/dam/spglobal/mi/en/documents/general/QR-Brief-Cold-Turkey-Navigating-Guidance-Withdrawal-with-Supply-Chain_Data.pdf">S&amp;P Global</a>)
"The question for managers is: Do they know about future performance substantially more than investors do?" NYU Professor Baruch Lev&nbsp;<a href="https://finance.yahoo.com/news/wall-st-economists-analysts-guess-forecasts-morning-brief-102219423.html">told me at the time</a>. "My guess is that in most cases managers aren't now better informed than investors. We are all in the dark. In that case, guidance is futile."
It's one thing for a company to revise guidance lower. It's another much scarier thing for a company to admit they just don't know where things are headed.
That's real uncertainty.
This speaks to&nbsp;<a href="https://www.tker.co/i/42137695/the-most-destabilizing-risks-are-the-ones-people-arent-talking-about">TKer Stock Market Truth No. 8</a>: "The most destabilizing risks are the ones people aren't talking about."
Pandemic risk was effectively on no one's radar going into 2020. Companies didn't have plans for addressing it, and it wasn't priced into the market. It's why the S&amp;P 500 was able to rally to its then record high of 3,393 on February 19 before tumbling 35% to its low of 2,191 on March 23.
Tariffs: Bad, but it could be worse &#x1f52d;
Most informed folks agree raising tariffs is a <a href="https://www.tker.co/p/wall-street-agrees-tariffs-are-bad">net negative for the economy</a>, so an uptick in uncertainty is warranted.
And lot of companies have said that the effect of tariffs&nbsp;<a href="https://www.tker.co/i/156333109/tariffs-are-not-factored-into-earnings-guidance">haven't been factored into their earnings guidance</a>. Maybe we'll soon hear about companies revising their guidance lower.
But will companies start withdrawing guidance in droves? I'm not convinced they will.
The threat of tariffs has been out there&nbsp;<a href="https://www.tker.co/p/wall-street-agrees-tariffs-are-bad">for months</a>. And for months, many companies have&nbsp;<a href="https://www.tker.co/p/companies-react-to-tariffs">announced plans for addressing</a>&nbsp;new tariffs, including&nbsp;<a href="https://www.tker.co/p/sales-pull-forward-frontrunning-tariffs">stockpiling goods</a>&nbsp;ahead of tariffs and&nbsp;<a href="https://www.tker.co/p/companies-pass-on-costs-tariffs-to-end-consumer">raising prices</a>&nbsp;once tariffs are imposed.
It would've been much worse if President Trump had announced the imposition of tariffs with no warning.
To be clear, tariffs and global pandemics are two very different things. But both are similar in that they come with supply chain disruptions and higher costs of goods. And the more advanced notice companies have, the more time they have to prepare operations for the risk.
This is not to say we won't experience market volatility in the coming months. The S&amp;P 500 experiences an&nbsp;<a href="https://www.tker.co/p/stock-market-down-days-drawdowns-down-years-normal">average annual max drawdown of 14%</a>.
But I think we should <a href="https://www.tker.co/p/dangerous-to-underestimate-corporate-america">be careful about underestimating</a> the resilience of Corporate America, especially when they've had time to prepare for what may be coming.

Equities

Market Summary

Broad U.S. Equity ETFs

Opinion

Markets

ETFs

When uncertainty becomes unambiguously high

INSE

Inspired Entertainment iGaming Content To Launch Through Rush Street Interactive' RushBet Platform In Mexico, Colombia and Peru And BetRivers Platform In Delaware

PMNT

Perfect Moment Says NYSE American Accepted Co. Plan To Regain Compliance

WIIM

SNES

SenesTech shares are trading lower after the company announced the exercise of warrants and will issue 1.498,872 shares of common stock.

Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) reported quarterly earnings of $0.14 per share. This is a 16.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported $11.54 million in sales this quarter. This is a 22.18 percent increase over sales of $9.45 million the same period last year.

Earnings

DXST

Decent Holding FY EPS $0.14 Up From $0.12 YoY, Sales $11.54M Up From $9.45M YoY

FLUX

Flux Power Appoints Krishna Vanka As Chief Executive Officer, Effective March 10, 2025

Earnings Misses

INZY

Inozyme Pharma FY 2024 GAAP EPS $(1.62) Misses $(1.60) Estimate; Co. Prioritizes Activities To Support Planned Biologics License Application Filing For INZ-701 In ENPP1 Deficiency, Announces 25% Workforce Reduction

Baird analyst Andrew Wittmann maintains WillScot Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSC#NASDAQ">WSC</a>) with a Neutral and lowers the price target from $38 to $32.

Baird Maintains Neutral on WillScot Holdings, Lowers Price Target to $32

SYNX

Silynxcom Has Received Two New Purchase Orders From An Elite Special Forces Unit Of The Israel Defense Forces For Advanced Tactical Communication Systems

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Compass Point analyst Floris Van Dijkum downgraded the rating for Pebblebrook Hotel Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) from Buy to Neutral. Pebblebrook Hotel shares closed at $12.11 on Friday. <a href="https://www.benzinga.com/quote/PEB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Compass Point analyst Floris Van Dijkum downgraded Host Hotels &amp; Resorts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HST#NASDAQ">HST</a>) from Buy to Neutral and lowered the price target from $20 to $18. Host Hotels shares closed at $16.33 on Friday. <a href="https://www.benzinga.com/quote/HST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Laurence Alexander downgraded The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Buy to Hold and lowered the price target from $423 to $380. Sherwin-Williams shares closed at $363.62 on Friday. <a href="https://www.benzinga.com/quote/SHW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Julian Mitchell downgraded Emerson Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from Equal-Weight to Underweight and cut the price target from $135 to $110. Emerson Electric shares closed at $118.61 on Friday. <a href="https://www.benzinga.com/quote/EMR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Blaine Heck downgraded the rating for Kilroy Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) from Overweight to Equal-Weight and lowered the price target from $43 to $35. Kilroy Realty shares closed at $33.32 on Friday. <a href="https://www.benzinga.com/quote/KRC/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SHW stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-1024x577.png" alt="" class="wp-image-816551" style="width:589px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/10083350/image-46.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44187903/top-2-consumer-stocks-that-could-blast-off-this-quarter">Top 2 Consumer Stocks That Could Blast Off This Quarter</a></li>
</ul>

Downgrades

Pre-Market Outlook

Trading Ideas

This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) ("SEALSQ" or "Company"), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced the signing of new distribution and sales agreements, significantly expanding the company's global footprint across Europe, Asia, and the Middle East. These agreements will enhance SEALSQ's ability to deliver its secure microcontrollers, post-quantum-ready solutions, and secure hardware platforms to a broader range of customers and industries worldwide.
New Distribution &amp; Sales Partnerships
<ul>
<li>Ozdisan – <a href="https://www.ozdisan.com/">https://www.ozdisan.com</a> &nbsp;</li>
</ul>
Covering Turkey, Egypt, and Greece, Ozdisan is one of the largest electronic component distributors in the region, with a strong focus on industrial applications, automotive electronics, and IoT solutions. Their deep market knowledge and extensive logistics capabilities position them as a key partner to accelerate SEALSQ's presence in these strategically important markets.
<ul>
<li>DTDS Technology – <a href="https://www.dtdsgroup.com/">https://www.dtdsgroup.com</a> &nbsp;</li>
</ul>
Operating across India, Singapore, Philippines, Thailand, Malaysia, Indonesia, and Vietnam, DTDS is a well-established distributor specializing in embedded systems, IoT components, and advanced semiconductor solutions. With their technical expertise and strong customer network, DTDS will help SEALSQ effectively support regional demand for secure hardware and post-quantum technologies.
<ul>
<li>Steliau Technology – <a href="https://www.steliau-technology.com/">https://www.steliau-technology.com</a> &nbsp;</li>
</ul>
Serving France, Spain, and Italy, Steliau is recognized for its engineering-driven approach, offering customized solutions and design support for industrial, consumer, and automotive electronics sectors. Their ability to provide value-added services will help SEALSQ deliver tailored security solutions that meet the evolving requirements of European manufacturers.
<ul>
<li>Nexus-GT – <a href="https://www.nexus-gt.com/">https://www.nexus-gt.com</a> &nbsp;</li>
</ul>
Based in Israel, Nexus-GT brings extensive experience as a manufacturer's representative, specializing in high-tech and semiconductor solutions. Their strong relationships with leading Israeli technology companies and deep understanding of the local innovation ecosystem will be instrumental in expanding SEALSQ's market presence in Israel's highly competitive technology landscape.

Global

LAES

SEALSQ Expands Global Reach With New Distribution And Sales Agreements Across Europe, Asia, And The Middle East, Enhancing Ability To Deliver Its Secure Microcontrollers, Post-Quantum-Ready Solutions, And Secure Hardware Platforms To A Broader Range Of Customers And Industries Worldwide

BLBX

Blackboxstocks shares are trading higher after the company signed a definitive merger agreement to acquire rare earth producer REalloys.

Press Releases

Australian Oilseeds Holdings Limited Announces Launch of New Investment Relationship Section on Official Website

Local Business Owner Kevin Chen Named to NSBA Leadership Council

Australian Oilseeds Announces Appointment of New Independent Auditor

Events

Sidoti Events, LLC's Virtual August Micro-Cap Conference

Australian Oilseeds Announces Attendance at Sidoti Micro-Cap Investor Conference

Restaurants

Australian Oilseeds Announces Fiscal 2024 Financial Results

Australian Oilseeds Expands Market Reach Through Strategic Partnership to Accelerate Growth in China

Australian Oilseeds Accelerates Growth with Expanded Distribution Across 1,000+ Woolworths Stores

Australian Oilseeds Announces First Quarter Fiscal 2025 Financial Results

Australian Oilseeds Announces Appointment of Amarjeet Singh as Chief Financial Officer

BYRN

COOT

DTIL

GNPX

GYRE

KELYA

KMDA

RNGR

SNCR

SONX

TRIB

TSX:MG

Forafric Global

Branchout Food

Barfresh Food Group

Bridgford Foods Corporation - Common Stock

Bridgford Foods

Better Choice Co

Beyond Meat

Australian Oilseeds Hldgs

DDC Enterprise Limited Class A Ordinary Shares

DDC Enterprise

Farmmi

Farmer Bros

The Hain Celestial Group, Inc. - Common Stock

Hain Celestial Group

CIMG

Coffee Holding Co

Laird Superfood

Lifeway Foods

Mama`s Creations

Moolec Science

Oriental Rise Holdings Limited - Ordinary Shares

Oriental Rise Holdings

TDH Hldgs

Planet Green Holdings

Rocky Mountain Chocolate Factory, Inc. - Common Stock

Rocky Mountain Chocolate

Sow Good

Steakholder Foods Ltd. - American Depositary Shares

Steakholder Foods

Top Wealth Group Holding Limited - Ordinary Shares

Top Wealth Group

Comments

Australian Oilseeds Hldgs

Australian Oilseeds Hldgs (COOT) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL